1
|
Schwab R, Stewen K, Battista MJ, Krajnak S, Anic K, Hasenburg A. P–298 High prevalence of depression and anxiety in patients with endometriosis during the SARS-CoV–2 pandemic in Germany. Hum Reprod 2021. [PMCID: PMC8385903 DOI: 10.1093/humrep/deab130.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Study question The aim was to assess the prevalence of self-reported symptoms of depression and anxiety and the moderating factors influencing mental symptoms during the COVID–19 pandemic. Summary answer Endometriosis patients were at risk of developing mental disorders during the pandemic. Associated risk factors were: reduction of the social network and the employment status. What is known already Endometriosis is a disease affecting up to 10% of women of fertile age. The leading symptoms are sub- or infertility and chronic pain. Additionally, the psychological impact on womeńs life is enormous. Women with endometriosis show higher rates of depression, anxiety and emotional distress, and these alterations in mental health were associated with the presence of pain rather than with the diagnosis of endometriosis. Additionally, a higher level of depression was observed in women with endometriosis. Study design, size, duration To assess the impact of the government-imposed social distancing or quarantine on mental health, an online questionnaire was placed on internet platforms of endometriosis patients support groups between 6th and 27th April 2020. Data collection and analysis were performed anonymously. Recruitment was conducted via a direct link to the survey and an invitation to participate was distributed via the internet platforms of patients support groups. Participants/materials, setting, methods 274 participants answered the Patient Health Questionnaire for Depression and Anxiety (PHQ–4), which screens for depression (PHQ–2), anxiety (GAD–2) and the level of psychological distress (PHQ–4). PHQ–2 and GAD–2 scores ≥ 3 are cut-off points between normal range and probable cases of mental disorders. A PHQ–4 score above 6 is indicative for severe symptoms. We used descriptive statistics to describe the study population. Correlates of depression and anxiety were identified using multivariate logistic regressions. Main results and the role of chance We showed that depression and anxiety were highly prevalent in endometriosis patients during the pandemic: 46.7% and 48.2% of participants showed scale scores of ≥ 3 on the PHQ–2 and GAD–2 scales, respectively. The mean PHQ–4 score was 5.72 (SD = 3.21), thus endometriosis patients were achieving significantly higher PHQ–4 sores (p < 0.001) than participants of a previously published study of the representative German population. Risk factors for higher probability of depressive disorders were the employment status (being employed, OR 2.890, p < 0.001), an important or severe reduction of the social network (OR 2.02, p < 0.05), having continuous pain (OR 1.83, p < 0.05) and high level of dysmenorrhea prior to the pandemic (OR 2.106, p < 0.05). Risk factors for higher probability of anxiety were the employment status (being employed, OR 2.697, p < 0.001), an important or severe reduction of the social network (OR 3.038, p < 0.01), and high level of dysmenorrhea prior to the pandemic (OR 1.750, p < 0.05). Endometriosis patients were at higher risk for developing mental health problems. The effective use of brief screening measures, such as PHQ–4, can be widely implemented even in the busy outpatient care of general practitioners and gynecologists and may help to reduce morbidity. Limitations, reasons for caution We used self-reports for assessment of anxiety and depression and those are susceptible to response bias, such as giving socially desirable responses. Moreover, as PHQ–4 is only a screening tool, the diagnosis must be confirmed in accordance to the appropriate DSM–V criteria. Wider implications of the findings: A better understanding of potential mental problems in endometriosis patients during stressful events, such as the COVID–19 pandemic or other comparable difficult environmental or social circumstances, is crucial for providing an optimal patient centered care in cases of upcoming stressful events. Trial registration number Not applicable
Collapse
Affiliation(s)
- R Schwab
- Mainz University Medical Center, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Germany
| | - K Stewen
- Mainz University Medical Center, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Germany
| | - M J Battista
- Mainz University Medical Center, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Germany
| | - S Krajnak
- Mainz University Medical Center, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Germany
| | - K Anic
- Mainz University Medical Center, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Germany
| | - A Hasenburg
- Mainz University Medical Center, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Germany
| |
Collapse
|
2
|
Thümmler S, Gindt M, Battista M, Askenazy F, Baubet T. [French translation of DIPA (Diagnostic Infant and Preschool Assessment, DSM-5)]. Encephale 2021; 48:107. [PMID: 33814169 DOI: 10.1016/j.encep.2020.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Accepted: 11/17/2020] [Indexed: 11/26/2022]
Affiliation(s)
- S Thümmler
- Service universitaire de psychiatrie de l'enfant et de l'adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 57, avenue de la Californie, 06200 Nice, France; Université Côte d'Azur, CoBTek, Fris, Nice, France.
| | - M Gindt
- Service universitaire de psychiatrie de l'enfant et de l'adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 57, avenue de la Californie, 06200 Nice, France; Université Côte d'Azur, CoBTek, Fris, Nice, France
| | - M Battista
- Service universitaire de psychiatrie de l'enfant et de l'adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 57, avenue de la Californie, 06200 Nice, France
| | - F Askenazy
- Service universitaire de psychiatrie de l'enfant et de l'adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 57, avenue de la Californie, 06200 Nice, France; Université Côte d'Azur, CoBTek, Fris, Nice, France
| | - T Baubet
- AP-HP, hôpital Avicenne, service de psychopathologie de l'enfant et de l'adolescent, Bobigny, France; CESP, inserm, université Sorbonne Paris Nord, Paris, France; Centre national de ressources et de résilience (CN2R), Paris, France
| |
Collapse
|
3
|
Gindt M, Fernandez A, Battista M, Richez A, Nachon O, Askenazy F. Preliminary findings of a longitudinal follow-up study of the paediatric population and their families during and after the coronavirus pandemic and the confinement. Eur Psychiatry 2021. [PMCID: PMC9475775 DOI: 10.1192/j.eurpsy.2021.971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
IntroductionPandemic are known to generate traumatic events, such as job losses or violence [1]. Several studies have shown that epidemics and related health measures (quarantine, confinement) lead to an increase of acute stress disorders (ASD), post-traumatic stress disorders (PTSD), anxiety and depression in the adult population [2]. In the pediatric population, few studies have been carried out on the psychiatric outcomes during and after epidemics and associated measures [3].ObjectivesThe aim of this study was to explore ASD symptoms during stay-at-home and Covid 19 pandemic and its impact on children and adolescent mental health.MethodsSixty participants (53% girls and 47% boys; mean age= 9 years 5 months) were included in this longitudinal study [4]. The measures consist in an emergency semi-directed interview designed to assess symptoms of ASD according to the age of children.ResultsPatients’ age modulated psychiatric outcomes. Children under the age of six shown more developmental regressions and more restlessness than older ones. Children from 6 to 12 years were characterized by more oppositional behaviors than adolescents. Finally, adolescents were characterized by more social isolation than younger ones. Other symptoms appear to be more stable across ages: sleep disturbance, fear behavior and somatization.ConclusionsYoung children experienced more externalized symptoms (opposition and agitation) and developmental regressions than older children [5]. Thus, it appears necessary during pandemic to take into account the psychiatric consequences of confinement to reduce psychosocial long-term outcomes in particular in younger patients who appeared to develop specific and age-related psychiatric disorders.
Collapse
|
4
|
Abstract
L’objectif de cet article est de présenter une revue de la littérature concernant les risques psychiatriques liées à la pandémie de la Covid 19, en population pédiatrique. Une revue de littérature a été réalisée sur la base de données Pubmed avec les mots clés : Covid 19, coronavirus, enfant, adolescent, santé mentale, conséquences psychiatriques et/ou psychologiques (Covid 19, Coronavirus, child, children, adolescent, mental health, psychiatric or psychological consequences). Nous présentons un état des lieux des recherches actuelles en fonction de trois facteurs : la crainte liée à la pandémie, les séquelles psychiques du confinement et les risques de traumatismes cumulatifs. Nous présenterons trois vignettes cliniques d’enfants ayant été suivi pendant la crise sanitaire suite au développement de symptômes liés à cette situation exceptionnelle. Nous terminerons par des perspectives sur la gestion de la crise sanitaire par les services de psychiatrie de l’enfant et de l’adolescent.
Collapse
Affiliation(s)
- M Gindt
- Service universitaire de psychiatrie de l'Enfant et de l'Adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 06200 Nice, France.,Université Côte d'Azur, CoBTek, FRIS, 06108 Nice cedex, France.,Centre expert du psychotrauma Paca Corse, France
| | - A Fernandez
- Service universitaire de psychiatrie de l'Enfant et de l'Adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 06200 Nice, France.,Université Côte d'Azur, CoBTek, FRIS, 06108 Nice cedex, France.,Centre expert du psychotrauma Paca Corse, France
| | - M Battista
- Service universitaire de psychiatrie de l'Enfant et de l'Adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 06200 Nice, France.,Centre expert du psychotrauma Paca Corse, France
| | - F Askenazy
- Service universitaire de psychiatrie de l'Enfant et de l'Adolescent, hôpitaux pédiatriques de Nice CHU-Lenval, 06200 Nice, France.,Université Côte d'Azur, CoBTek, FRIS, 06108 Nice cedex, France.,Centre expert du psychotrauma Paca Corse, France
| |
Collapse
|
5
|
Almstedt K, Mendoza S, Battista MJ, Steetskamp J, Heimes AS, Krajnak S, Poplawski A, Hasenburg A, Schmidt M. EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer: Impact on clinical decisions and clinico-pathological factors influencing its application. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
| | | | | | | | | | | | - A Poplawski
- Institut für Medizinische Biometrie, Epidemiologie and Informatik (IMBEI)
| | | | | |
Collapse
|
6
|
van der Ven J, Linz V, Schwab R, Komoss S, Schmalfeldt B, Sehouli J, Hasenburg A, Battista MJ. Management of patients with STIC lesions in Germany – First results of a questionnaire based AGO Ovar survey. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- J van der Ven
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - V Linz
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - R Schwab
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - S Komoss
- Universitätsklinik Tübingen, Department für Frauengesundheit
- Arbeitsgemeinschaft Gynäkologische Onkologie e.V., Kommission Ovar
| | - B Schmalfeldt
- Arbeitsgemeinschaft Gynäkologische Onkologie e.V., Kommission Ovar
- Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Gynäkologie
| | - J Sehouli
- Arbeitsgemeinschaft Gynäkologische Onkologie e.V., Kommission Ovar
- Charité – Universitätsmedizin Berlin, Klinik für Gynäkologie mit Zentrum für onkologische Chirurgie
| | - A Hasenburg
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
- Arbeitsgemeinschaft Gynäkologische Onkologie e.V., Kommission Ovar
| | - MJ Battista
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| |
Collapse
|
7
|
Theis S, Battista MJ, Hasenburg A, Stewen K, Weikel W, Lebrecht A. Magnetische Sentinellymphknoten (SLN)-Markierung beim Mammakarzinom. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- S Theis
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - MJ Battista
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - A Hasenburg
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - K Stewen
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - W Weikel
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| | - A Lebrecht
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
| |
Collapse
|
8
|
Almstedt K, Mendoza S, Otto M, Battista MJ, Steetskamp J, Heimes AS, Krajnak S, Poplawski A, Gerhold-Ay A, Hasenburg A, Denkert C, Schmidt M. EndoPredict ® in early hormone receptor-positive, HER2-negative breast cancer. Breast Cancer Res Treat 2020; 182:137-146. [PMID: 32436145 PMCID: PMC7275019 DOI: 10.1007/s10549-020-05688-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 05/11/2020] [Indexed: 01/13/2023]
Abstract
Purpose Evaluating consecutive early breast cancer patients, we analyzed both the impact of EndoPredict® on clinical decisions as well as clinico-pathological factors influencing the decision to perform this gene expression test. Methods Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative early breast cancer patients treated between 2011 and 2016 were included in this study to investigate the role of EndoPredict® (EPclin) in the treatment of early breast cancer. A main study aim was to analyze the changes in therapy recommendations with and without EPclin. In addition, the impact of clinico-pathological parameters for the decision to perform EPclin was examined by Pearson's chi-squared test (χ2-test) and Fisher's exact test as well as univariate and multivariate logistic regressions. Results In a cohort of 869 consecutive early HR-positive, HER-negative breast cancer patients, EPclin was utilized in 156 (18.0%) patients. EPclin led to changes in therapy recommendations in 33.3% (n = 52), with both therapy escalation in 19.2% (n = 30) and de-escalation in 14.1% (n = 22). The clinico-pathological factors influencing the use of EPclin were age (P < 0.001, odds ratio [OR] 0.498), tumor size (P = 0.011, OR 0.071), nodal status (P = 0.021, OR 1.674), histological grade (P = 0.043, OR 0.432), and Ki-67 (P < 0.001, OR 3.599). Conclusions EPclin led to a change in therapy recommendations in one third of the patients. Clinico-pathological parameters such as younger age, smaller tumor size, positive nodal status, intermediate histological grade and intermediate Ki-67 had a significant influence on the use of EndoPredict®. Electronic supplementary material The online version of this article (10.1007/s10549-020-05688-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- K Almstedt
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
| | - S Mendoza
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| | - M Otto
- Institute for Molecular Pathology, Trier, Germany
| | - M J Battista
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| | - J Steetskamp
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| | - A S Heimes
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| | - S Krajnak
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| | - A Poplawski
- Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany
| | - A Gerhold-Ay
- Institute of Medical Biometry, Epidemiology and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany
| | - A Hasenburg
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| | - C Denkert
- Institute of Pathology, Philipps-University Marburg and UKGM Marburg, Marburg, Germany
| | - M Schmidt
- Department of Obstetrics and Gynecology, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany
| |
Collapse
|
9
|
Schmidt M, Hönig A, Verhoeven C, Almstedt K, Battista M, Lenhard HG, Krijgh J, Coelingh Bennink H. Abstract P4-13-12: Estetrol for treatment of advanced ER+ breast cancer. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-13-12] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Currently, a multi-center, open-label, phase I/IIA, dose-escalation study with the fetal estrogen estetrol (E4) is ongoing in Germany in postmenopausal patients with advanced breast cancer (ABCE4 study). The objective of the study is to assess safety and tolerability of different doses of E4 (range 20-60 mg per day). In addition initial anti-tumor response will be determined.
Study design: Patients are treated for 12 weeks with E4; 4 weeks in Phase I and thereafter 8 weeks in Phase IIA. Phase I of the study will follow the traditional 3 + 3 design to determine the optimal dose in patients with advanced breast cancer. Patients are treated in cohorts of three all receiving the same dose. Occurrence of dose limiting toxicity (DLT) at completion of phase I (4 weeks treatment) will determine escalation to the next higher dose in the study. After completion of Phase I, patients will continue treatment for 8 weeks to assess preliminary anti-tumor response in Phase IIA. Treatment may continue beyond 12 weeks based on evaluation of the patient and her treating physician.
Results: Phase I of the first treatment cohort with 20 mg E4 per day has been completed. A total of six postmenopausal women with advanced breast cancer has been included in the first cohort. One patient withdrew consent before treatment with E4 started. She was replaced. Two patients discontinued the study before completion of Phase I for reasons other than DLTs. These patients were unevaluable for toxicity and were also replaced. Three patients completed Phase I. One patient discontinued the study during Phase IIA due to disease progression after 9,5 weeks of E4 treatment. One patient completed both the Phase I and IIA part of the study. She had stable disease at study completion and wanted to continue E4 treatment because of improved well-being. Tumor assessment after 24 weeks of E4 treatment showed again stable disease. One patient is presently in Phase IIA of the study.
None of the patients experienced a DLT. The 20 mg E4 dose was well tolerated by all patients. In total 17 adverse events were reported. Adverse events were mainly of mild or moderate intensity. Five of 17 events fulfilled criteria of seriousness; none of these events were considered to be related to the E4 treatment. Four events were considered to be possibly related to the E4 treatment. These events were increased endometrial thickness, dry skin, pruritus and fatigue, all of mild intensity. A remarkable finding was that three of the five patients treated with E4 reported to the investigator to “feel better” than before the start of E4 treatment. This '”feeling better” was described by one of the patients as: '”feeling less down and exhausted; instead feeling much more optimistic, powerful and positive when taking E4”.
So far anti-tumor response could be estimated in one patient. This patient, who started the study with progressive disease, had stable disease as shown by tumor assessments after 12 weeks and 24 weeks of E4 treatment.
Conclusion: Based on these results, we conclude that a daily dose of 20 mg E4 is well tolerated. The majority of patients experienced favorable subjective effects on wellbeing. The data obtained with the 20 mg dose E4 allow dose escalation to the next higher dose of 40 mg E4 per day.
Citation Format: Schmidt M, Hönig A, Verhoeven C, Almstedt K, Battista M, Lenhard HG, Krijgh J, Coelingh Bennink H. Estetrol for treatment of advanced ER+ breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-13-12.
Collapse
Affiliation(s)
- M Schmidt
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - A Hönig
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - C Verhoeven
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - K Almstedt
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - M Battista
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - HG Lenhard
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - J Krijgh
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| | - H Coelingh Bennink
- Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, University of Mainz, Mainz, Germany; Geburtshilfe und Frauenheilkunde, Katholisches Klinikum Mainz, Mainz, Germany; Pantarhei Oncology BV, Zeist, Netherlands
| |
Collapse
|
10
|
Heimes AS, Jäkel J, Almstedt K, Weyer-Eiberich V, Elger T, Krajnak S, Brenner W, Hasenburg A, Schmidt M, Battista MJ. A retrospective analysis of immunohistochemical determined IRF4 (interferon regulating factor 4) expression in a consecutive cohort of 114 ovarian cancer patients. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- AS Heimes
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - J Jäkel
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Institut für Pathologie, Mainz, Deutschland
| | - K Almstedt
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - V Weyer-Eiberich
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, IMBEI, Mainz, Deutschland
| | - T Elger
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - S Krajnak
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - W Brenner
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - A Hasenburg
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - M Schmidt
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - MJ Battista
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| |
Collapse
|
11
|
Hedri A, Lebrecht A, Battista MJ, Hasenburg A, Schmidt M. Male breast cancer: clinical presentation, diagnosis and therapy. A 30-year experience at the Department of Obstetrics and Gynecology, Medical Center Mainz, Germany. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- A Hedri
- Unifrauenklinik Mainz, Gynäkologie und Geburtshilfe, Mainz, Deutschland
| | - A Lebrecht
- Unifrauenklinik Mainz, Mainz, Deutschland
| | | | - A Hasenburg
- Unifrauenklinik Mainz, Gynäkologie und Geburtshilfe, Mainz, Deutschland
| | - M Schmidt
- Unifrauenklinik Mainz, Gynäkologie und Geburtshilfe, Mainz, Deutschland
| |
Collapse
|
12
|
Nezi S, Sicking I, Almstedt K, Battista M, Heimes AS, Krajnak S, Steetskamp J, Hasenburg A, Schmidt M. Risikofaktoren für Chemotherapie-assoziierte venöse Thrombosen bei gynäkoonkologischen Patientinnen. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- S Nezi
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - I Sicking
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - K Almstedt
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - M Battista
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - AS Heimes
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - S Krajnak
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - J Steetskamp
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - A Hasenburg
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| | - M Schmidt
- Universitätsmedizin Mainz, Klinik und Poliklinik für Geburtshilfe und Frauengesundheit, Mainz, Deutschland
| |
Collapse
|
13
|
Anglani F, Terrin L, Brugnara M, Battista M, Cantaluppi V, Ceol M, Bertoldi L, Valle G, Joy MP, Pober BR, Longoni M. Hypercalciuria and nephrolithiasis: Expanding the renal phenotype of Donnai-Barrow syndrome. Clin Genet 2018. [PMID: 29532936 DOI: 10.1111/cge.13242] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Whole exome sequencing detected novel likely pathogenic variants in LRP2 gene in 2 patients presenting with hearing and vision loss, and the Dent disease (DD) classical renal phenotype, that is, low molecular weight proteinuria (LMWP), hypercalciuria and nephrocalcinosis/nephrolithiasis. We propose that a subset of patients presenting as DD may represent unrecognized cases or mild forms of Donnai-Barrow/facio-oculo-acustico-renal (DB/FOAR) syndrome or be on the phenotypic continuum between the 2 conditions.
Collapse
Affiliation(s)
- F Anglani
- Clinical Nephrology Division, Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - L Terrin
- Clinical Nephrology Division, Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - M Brugnara
- Pediatric Division, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy
| | - M Battista
- Nephrology and Transplantation Division, Department of Clinical and Experimental Medicine, Amedeo Avogadro University, Novara, Italy
| | - V Cantaluppi
- Nephrology and Transplantation Division, Department of Clinical and Experimental Medicine, Amedeo Avogadro University, Novara, Italy
| | - M Ceol
- Clinical Nephrology Division, Department of Medicine-DIMED, University of Padua, Padua, Italy
| | - L Bertoldi
- CRIBI Biotechnology Centre, University of Padua, Padua, Italy
| | - G Valle
- CRIBI Biotechnology Centre, University of Padua, Padua, Italy
| | - M P Joy
- Pediatric Surgical Research Laboratories, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - B R Pober
- Pediatric Surgical Research Laboratories, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - M Longoni
- Pediatric Surgical Research Laboratories, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
14
|
Schmidt M, Madjar K, Heimes AS, Battista M, Lebrecht A, Almsetdt K, Hasenburg A, Rahnenführer J, Hengstler JG. Abstract P2-05-22: Prognostic significance of nuclear factor kappa B in node-negative breast cancer is most pronounced in luminal B breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p2-05-22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The importance of the cellular as well as the humoral immune system is increasingly recognized in breast cancer. The transcription factor nuclear factor kappa B (NFKB1) plays an important role in immune cell development. We examined the prognostic significance of NFKB1 in node-negative breast cancer.
Methods: Microarray based gene-expression data for NFKB1 (209239_at) were analysed in four previously published cohorts (Mainz, Rotterdam, Transbig, Yu) of node-negative breast cancer patients not treated with adjuvant therapy (n=824). A meta-analysis of previously published cohorts was performed using a random effects model. Intrinsic subtypes were determined using gene-expression data. Prognostic significance of NFKB1 for metastasis-free survival (MFS) was examined in the whole cohort, in estrogen receptor (ER) positive as well as ER negative patients, and in different intrinsic subtypes: luminal A, liminal B, basal-like, HER2-enriched (HER2-E), and normal-like. Independent prognostic relevance was analysed using multivariate Cox regression.
Results: Higher RNA expression of NFKB1 was related to better MFS in a meta-analysis of the whole cohort (HR 0.48, 95% CI 0.34-0.67, P<0.0001). NFKB1 was significantly associated with MFS only in ER positive (HR 0.41, 95% CI 0.24−0.69, P=0.0008) but not in ER negative (HR 0.76, 95% CI 0.39−1.48, P=0.4245) patients. Regarding intrinsic subtypes, the prognostic significance of NFKB1 was most pronounced in luminal B breast cancer (HR 0.40, 95% CI 0.17−0.93, P=0.0338) as compared to luminal A (HR 0.67, 95% CI 0.16−2.73, P=0.5738), basal-like (HR 0.67, 95% CI 0.29−1.56), P=0.3484), HER2-E (HR 0.70, 95% CI 0.25−2.00, P=0.5083), and normal-like (HR 0.49, 95% CI 0.18−1.32, P=0.1579) breast cancer. However, NFKB1 failed to show independent prognostic significance (HR 0.72, 95% CI 0.42-1.24, P=0.235) in multivariate analysis. Only histological grade of differentiation (HR 2.06, 95% CI 1.27-3.35, P=0.003) and tumor size (HR 1.58, 95% CI 1.01-2.48, P=0.045), but neither age nor HER2 status nor hormone receptor status maintained an independent prognostic association with MFS.
Conclusions: The transcription factor NFKB1 shows prognostic significance in node-negative breast cancer. Higher expression of NFKB1 is associated with improved outcome. The prognostic impact of NFKB1 differs between intrinsic subtypes and is most pronounced in luminal B breast cancer.
Citation Format: Schmidt M, Madjar K, Heimes A-S, Battista M, Lebrecht A, Almsetdt K, Hasenburg A, Rahnenführer J, Hengstler JG. Prognostic significance of nuclear factor kappa B in node-negative breast cancer is most pronounced in luminal B breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-22.
Collapse
Affiliation(s)
- M Schmidt
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - K Madjar
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - A-S Heimes
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - M Battista
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - A Lebrecht
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - K Almsetdt
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - A Hasenburg
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - J Rahnenführer
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| | - JG Hengstler
- University Medical Center, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Technical University, Dortmund, Germany
| |
Collapse
|
15
|
Makris GM, Chrelias C, Papanota A, Battista MJ, Papantoniou N. Ovarian tumors: Should the cervix be examined first? EUR J GYNAECOL ONCOL 2017; 38:462-464. [PMID: 29693893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
There is a controversy regarding ovarian metastasis in early-stage adenocareinoma of the uterine cervix. The authors present the case of a 5 1-year-old woman that at the time of diagnosis was thought to suffer from a Stage II cervical carcinoma and a synchronous ovarian carcinoma, that turned out to be an ovarian metastasis from the endocervical adenocarcinoma, as attested morphologically, histochemically, and immunohistochemically. Radical hysterectomy with oophorectomy, excision of the omentum, lymph node excision, and cytological sampling of the peritoneal cavity were carried out. It is important to always bear in mind that even low-grade adenocarcinomas of the cervix can be metastatic to the ovaries. Clinicians have to be careful when managing those cases, while further investigation is needed in order to determine the exact mechanism of those metastases and the criteria needed in order to preserve the ovaries in young patients.
Collapse
|
16
|
Almstedt K, van de Sandt L, Sicking I, Battista M, Heimes AS, Lebrecht A, Edlund K, Rahnenführer J, Hengstler JG, Hasenburg A, Schmidt M. Prognostic significance of the chemokine CXCL13 in node-negative breast cancer. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
17
|
Battista MJ, Steiner E, Schmidt M, Eichbaum M, Makris GM, Heimes AS, Almstedt K, Mallmann P, Hasenburg A. Versorgung von Patientinnen mit Endometriumkarzinom in Deutschland – Erste Ergebnisse der AGO Umfrage aus den Jahren 2006, 2009, 2013 und 2015. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
18
|
Stewen K, Strobel C, Battista M, Rieks N, Lebrecht A, Hasenburg A, Schmidt M. Prognosefaktoren des DCIS. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
19
|
Schmidt M, van de Sandt L, Heimes AS, Battista M, Lebrecht A, Almstedt K, Hoffmann G, Rahnenführer J, Hengstler JG. Abstract P2-08-07: Prognostic significance of immune checkpoint receptors in node-negative breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p2-08-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Immune checkpoint blockade is increasingly discussed in breast cancer. We examined the prognostic significance of the immune checkpoint receptors cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) in node-negative breast cancer.
Methods: Microarray based gene-expression data for CTLA-4 (221331_x_at) and PD-1 (207634_at) were analysed in four previously published cohorts (Mainz, Rotterdam, Transbig, Yu) of node-negative breast cancer patients not treated with adjuvant therapy (n=824). A meta-analysis of previously published cohorts was performed using a random effects model. Prognostic significance of CTLA-4 as well as PD-1 for metastasis-free survival (MFS) was examined in the whole cohort and in different molecular subtypes: luminal (ER+/HER2-), basal-like (ER-/HER2-) and HER2+. Independent prognostic relevance was analysed using multivariate Cox regression.
Results: Higher RNA expression of CTLA-4 was related to better MFS in a meta-analysis of the whole cohort (HR 0.58, 95% CI 0.38-0.88, P=0.0102). Prognostic significance was most pronounced in the HER2+ positive molecular subtype (HR 0.23, 95% CI 0.08-0.65, P=0.0062) as compared to luminal (HR 0.68, 95% CI 0.39-1.18, P=0.1744) and basal-like (HR 0.53, 95% CI 0.25-1.15), P=0.1087) carcinomas of the breast. PD-1 RNA expression, however, was not associated with outcome in the whole cohort of patients (HR 0.88, 95% CI 0.32-2.43, P=0.1853). A trend for improved survival was noticed in basal-like breast cancer (HR 0.40, 95% CI 0.15-1.08, P=0.0701). Neither luminal (HR 0.81, 95% CI 0.28-2.36, P=0.2122) nor HER2+ (HR 0.85, 95% CI 0.27-2.68, P=0.7759) patients showed an association of PD-1 with MFS. CTLA-4 showed independent prognostic significance (HR 0.393, 95% CI 0.224-0.688, P=0.001) in multivariate analysis. In addition to CTLA-4, only histological grade of differentiation (HR 2.335, 95% CI 1.490-3.660, P<0.0001) and tumor size (HR 1.924, 95% CI 1.260-2.937, P=0.002), but neither PD-1 nor age nor HER2 status nor hormone receptor status retained an independent prognostic association with MFS.
Conclusions: The immune checkpoint receptor CTLA-4 has independent prognostic significance in node-negative breast cancer. Higher expression of CTLA-4 is associated with improved outcome. The prognostic impact of CTLA-4 differs between molecular subtypes and is most pronounced in HER2+ breast cancer.
Citation Format: Schmidt M, van de Sandt L, Heimes A-S, Battista M, Lebrecht A, Almstedt K, Hoffmann G, Rahnenführer J, Hengstler JG. Prognostic significance of immune checkpoint receptors in node-negative breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P2-08-07.
Collapse
Affiliation(s)
- M Schmidt
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - L van de Sandt
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - A-S Heimes
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - M Battista
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - A Lebrecht
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - K Almstedt
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - G Hoffmann
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - J Rahnenführer
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| | - JG Hengstler
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo) at Technical University, Dortmund, Germany
| |
Collapse
|
20
|
Picciotti PM, Battista M, Pandolfini M, Paludetti G, Ausili E, Romagnoli C, Rendeli C. Audiological evaluation in children affected by myelomeningocele. Childs Nerv Syst 2015; 31:2321-4. [PMID: 26351072 DOI: 10.1007/s00381-015-2898-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2015] [Accepted: 09/01/2015] [Indexed: 11/24/2022]
Abstract
PURPOSE The aim of the present study is to evaluate the auditory system in children affected by myelomeningocele and comparing the results with clinical neurological conditions. MATERIALS AND METHODS Forty-three children, aged between 7 and 26 years, affected by myelomeningocele were investigated by means of subjective tonal audiometry and objective impedance audiometry (tympanometry and acoustic stapedial reflex). RESULTS Audiological evaluation showed an alteration in 32 patients (74%%). Nine patients presented a mild hearing loss: bilateral in six cases (three sensorineural, one mixed, and two conductive) and unilateral in three cases (two mixed and one conductive). One patient had moderate unilateral conductive deafness and, finally another one severe unilateral sensorineural. Almost all patients with deafness were affected by myelomeningocele and Chiari II. Stapedial-cochlear reflex investigation showed an alteration in 30 patients (70%): 9 of these also showed deafness while the remaining 21 was normal hearing. In these 30 patients, we demonstrated the presence of myelomeningocele, hydrocephalus, and Chiari II malformation in 21 subjects (70%). CONCLUSION Otoneurological evaluation is important in myelomeningocele not only at the birth but also in the follow-up. It could have an important prognostic role for neurological impairment.
Collapse
Affiliation(s)
- Pasqualina Maria Picciotti
- Department of Otolaryngology Head and Neck Surgery and Paediatrics, Rome, Italy. .,Department of Otolaryngology, Catholic University of Sacred Heart, Largo A. Gemelli 8, 00168, Rome, Italy.
| | - M Battista
- Department of Otolaryngology Head and Neck Surgery and Paediatrics, Rome, Italy
| | - M Pandolfini
- Department of Otolaryngology Head and Neck Surgery and Paediatrics, Rome, Italy
| | - G Paludetti
- Department of Otolaryngology Head and Neck Surgery and Paediatrics, Rome, Italy
| | - E Ausili
- Catholic University of Sacred Heart, Rome, Italy
| | - C Romagnoli
- Catholic University of Sacred Heart, Rome, Italy
| | - C Rendeli
- Catholic University of Sacred Heart, Rome, Italy
| |
Collapse
|
21
|
Albrich S, Steetskamp J, Rommens K, Porta S, Battista M, Hoffmann G, Skala C. Detection of Subpubic Tumor Causing Bladder Outlet Obstruction by 3D Perineal Ultrasound. Geburtshilfe Frauenheilkd 2015; 75:719-722. [PMID: 26257409 DOI: 10.1055/s-0035-1546219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2015] [Revised: 06/03/2015] [Accepted: 06/12/2015] [Indexed: 10/23/2022] Open
Abstract
This case report shows that 3D perineal ultrasound can be superior to clinical examination and routine 2D perineal ultrasound in the detection of an unusual subpubic tumor. A 73-year-old female patient was referred to our urogynecological outpatient unit complaining of over-active bladder symptoms and voiding dysfunction for 3 years. Gynecological examination found no signs of pelvic organ prolapse or abnormality in the vaginal cavity. Routine 2D perineal ultrasound showed substantial residual urine (ca. 300 ml on catheter) and limited bladder neck mobility, but no signs of pelvic organ prolapse. Use of standardized 3D perineal ultrasound revealed a 24 × 26 × 32 mm spherical, hypoechoic tumor below the pubic symphysis between the distal urethra and the pubic bones. This structure was mistaken for the pubic symphysis in the midline on 2D ultrasound performed earlier. At surgery, the tumor was completely excised through a vaginal incision between the urethra and the pubic symphysis. After an uneventful postoperative recovery the patient developed de-novo stress urinary incontinence, which was corrected successfully by the insertion of a retropubic tension-free suburethral sling after an interval of 8 weeks. After a further follow-up of 8 weeks the patient reported well-being, urinary continence and no voiding dysfunction; no abnormalities were found on examination. In conclusion, 3D perineal ultrasound is a useful additional tool for the diagnostic workup of bladder outlet obstruction.
Collapse
Affiliation(s)
- S Albrich
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| | - J Steetskamp
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| | - K Rommens
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| | - S Porta
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| | - M Battista
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| | - G Hoffmann
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| | - C Skala
- Department of Obstetrics and Gynecology, Johannes-Gutenberg-University Mainz, Mainz
| |
Collapse
|
22
|
Makris GM, Siristatidis C, Battista MJ, Chrelias C. Ovarian carcinosarcoma: a case report, diagnosis, treatment and literature review. Hippokratia 2015; 19:256-259. [PMID: 27418786 PMCID: PMC4938474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
BACKGROUND/AIM This report aims to present a rare case of ovarian carcinosarcoma and its current, optimal diagnosis and therapy strategy. DESCRIPTION OF CASE We report the case of a 70-year-old patient, who presented at the Obstetrics and Gynecology Department of the University Hospital of Mainz, with a short history of increased abdominal circumference. CONCLUSION The symptoms, diagnosis, and therapy of carcinosarcoma follow the pattern of a high grade epithelial ovarian cancer, fallopian cancer and primary peritoneal cancer. The rarity of this disease is a barrier to conducting prospective trials and establishing guidelines for high-quality evidence data. Hippokratia 2015; 19 (3): 256-259.
Collapse
Affiliation(s)
- G M Makris
- Department of Obstetrics and Gynecology, University Medical Center Mainz, "Johannes Gutenberg" University, Mainz, Germany
| | - C Siristatidis
- 3 Department of Obstetrics and Gynecology, University of Athens, "Attikon" General hospital, Chaidari, Athens, Greece
| | - M J Battista
- Department of Obstetrics and Gynecology, University Medical Center Mainz, "Johannes Gutenberg" University, Mainz, Germany
| | - C Chrelias
- 3 Department of Obstetrics and Gynecology, University of Athens, "Attikon" General hospital, Chaidari, Athens, Greece
| |
Collapse
|
23
|
Heimes AS, van de Sandt L, Edlund K, Sicking I, Battista M, Lebrecht A, Rahnenführer J, Hengstler JG, Schmidt M. Prognostische Signifikanz von IRF4 (interferonregulierender Faktor 4) bei nodal-negativen Mammakarzinomen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
24
|
Sicking I, Rommens K, Battista MJ, Lebrecht A, Cotarelo C, Hoffmann G, Hengstler JG, Schmidt M. Prognostische Bedeutung von Cyclooxygenase-2 beim nodal-negativen, unbehandelten Mammakarzinom. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
25
|
Schmidt M, Dogan G, Battista M, Lenhard HG, Lebrecht A, Hönig A, Hoffmann G, Seufert R, Cotarelo C. Zusammenhang zwischen urokinase-typ Plasminogen Aktivator (uPA)/Plasminogen Aktivator Inhibitor-1 (PAI-1) und intrinsischen Subtypen beim frühen Mammakarzinom. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
26
|
de Corso E, Battista M, Pandolfini M, Liberati L, Baroni S, Romanello M, Passali GC, Fetoni AR, Sergi B, Di Nardo W, Paludetti G. Role of inflammation in non-allergic rhinitis. Rhinology 2014; 52:142-9. [PMID: 24932626 DOI: 10.4193/rhino13.102] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE To investigate the role of inflammation in non-allergic rhinitis (NAR) patients in a large series to establish the prevalence of different NAR-subtypes, clinical features and the role of nasal cytology in the diagnostic algorithm. METHODOLOGY Patients were selected out of 3650 individuals who spontaneously presented at our institution. We consecutively enrolled 519 NAR-patients in an analytical cross-sectional study between November 2007 and June 2013 (level of evidence: 3b). All patients underwent rhinological evaluation including symptoms questionnaire, endoscopy, CT scan, allergy tests and nasal cytology. RESULTS The inflammatory cell infiltrate affects the severity of symptoms differently, allowing for identification of different phenotypes of NAR. We distinguished two groups: “NAR without inflammation”(NAR-) and “NAR with inflammation”(NAR+), in addition to different NAR-subtypes with inflammation. A significant difference was observed in terms of clinical symptoms and association with comorbidities (previously diagnosed asthma and aspirin intolerance) between NAR–, NAR+ and between different NAR+ subtypes. CONCLUSION Our data suggest that NAR- and NAR with neutrophils behave similarly, showing lower symptom score values and a lower risk of association with comorbidities compared to NAR with eosinophils and mast cells (singularly or mixed). In our belief it is very important to establish the presence and type of inflammation in non-allergic rhinitis patients and nasal cytology is a very useful test in correct differential diagnosis.
Collapse
|
27
|
Schachtner T, Reinke P, Dorje C, Mjoen G, Midtvedt K, Strom EH, Oyen O, Jenssen T, Reisaeter AV, Smedbraaten YV, Sagedal S, Mjoen G, Fagerland MW, Hartmann A, Thiel S, Zulkarnaev A, Vatazin A, Vincenti F, Harel E, Kantor A, Thurison T, Hoyer-Hansen G, Craik C, Kute VB, Shah PS, Vanikar AV, Modi PR, Shah PR, Gumber MR, Patel HV, Engineer DP, Shah VR, Rizvi J, Trivedi HL, Malheiro J, Dias L, Martins LS, Fonseca I, Pedroso S, Almeida M, Castro-Henriques A, Cabrita A, Costa C, Ritta M, Sinesi F, Sidoti F, Mantovani S, Di Nauta A, Messina M, Cavallo R, Verflova A, Svobodova E, Slatinska J, Slavcev A, Pokorna E, Viklicky O, Yagan J, Chandraker A, Messina M, Diena D, Tognarelli G, Ranghino A, Bussolino S, Fop F, Segoloni GP, Biancone L, Leone F, Mauro MV, Gigliotti P, Lofaro D, Greco F, Perugini D, Papalia T, Perri A, Vizza D, Giraldi C, Bonofilgio R, Luis-Lima S, Marrero D, Gonzalez-Rinne A, Torres A, Salido E, Jimenez-Sosa A, Aldea-Perona A, Gonzalez-Posada JM, Perez-Tamajon L, Rodriguez-Hernandez A, Negrin-Mena N, Porrini E, Mjoen G, Pihlstrom H, Dahle DO, Holdaas H, Von Der Lippe N, Waldum B, Brekke F, Amro A, Reisaeter AV, Os I, Klin P, Sanabria H, Bridoux P, De Francesco J, Fortunato RM, Raffaele P, Kong J, Son SH, Kwon HY, Whang EJ, Choi WY, Yoon CS, Thanaraj V, Theakstone A, Stopper K, Ferraro A, Bhattacharjya S, Devonald M, Williams A, Mella A, Messina M, Gallo E, Fop F, Di Vico MC, Diena D, Pagani F, Gai M, Ranghino A, Segoloni GP, Biancone L, Cho HJ, Nho KW, Park SK, Kim SB, Yoshida K, Ishii D, Ohyama T, Kohguchi D, Takeuchi Y, Varga A, Sandor B, Kalmar-Nagy K, Toth A, Toth K, Szakaly P, Zulkarnaev A, Vatazin A, Kildushevsky A, Fedulkina V, Kantaria R, Staeck O, Halleck F, Rissling O, Naik M, Neumayer HH, Budde K, Khadzhynov D, Bhadauria D, Kaul A, Prasad N, Sharma RK, Sezer S, Bal Z, Erkmen Uyar M, Guliyev O, Erdemir B, Colak T, Ozdemir N, Haberal M, Caliskan Y, Yazici H, Artan AS, Oto OA, Aysuna N, Bozfakioglu S, Turkmen A, Yildiz A, Sever MS, Yagisawa T, Nukui A, Kimura T, Nannmoku K, Kurosawa A, Sakuma Y, Miki A, Damiano F, Ligabue G, De Biasi S, Granito M, Cossarizza A, Cappelli G, Martins LS, Fonseca I, Malheiro J, Henriques AC, Pedroso S, Almeida M, Dias L, Davide J, Cabrita A, Von During ME, Jenssen TG, Bollerslev J, Godang K, Asberg A, Hartmann A, Bachelet T, Martinez C, Bello A, Kejji S, Couzi L, Guidicelli G, Lepreux S, Visentin J, Congy-Jolivet N, Rostaing L, Taupin JL, Kamar N, Merville P, Sezer S, Bal Z, Erkmen Uyar M, Ozdemir H, Guliyev O, Yildirim S, Tutal E, Ozdemir N, Haberal M, Sezer S, Erkmen Uyar M, Bal Z, Guliyev O, Sayin B, Colak T, Ozdemir Acar N, Haberal M, Banasik M, Boratynska M, Koscielska-Kasprzak K, Kaminska D, Bartoszek D, Mazanowska O, Krajewska M, Zmonarski S, Chudoba P, Dawiskiba T, Protasiewicz M, Halon A, Sas A, Kaminska M, Klinger M, Stefanovic N, Cvetkovic T, Velickovic - Radovanovic R, Jevtovic - Stoimenov T, Vlahovic P, Rungta R, Das P, Ray DS, Gupta S, Kolonko A, Szotowska M, Kuczera P, Chudek J, Wiecek A, Sikora-Grabka E, Adamczak M, Szotowska M, Kuczera P, Madej P, Wiecek A, Amanova A, Kendi Celebi Z, Bakar F, Caglayan MG, Keven K, Massimetti C, Imperato G, Zampi G, De Vincenzi A, Fabbri GDD, Brescia F, Feriozzi S, Filipov JJ, Zlatkov BK, Dimitrov EP, Svinarov DA, Poesen R, De Vusser K, Evenepoel P, Kuypers D, Naesens M, Meijers B, Kocak H, Yilmaz VT, Yilmaz F, Uslu HB, Aliosmanoglu I, Ermis H, Dinckan A, Cetinkaya R, Ersoy FF, Suleymanlar G, Fonseca I, Oliveira JC, Santos J, Martins LS, Almeida M, Dias L, Pedroso S, Lobato L, Castro-Henriques A, Mendonca D, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Goto N, Narumi S, Kobayashi T, Dahle DO, Holdaas H, Reisaeter AV, Dorje C, Mjoen G, Line PD, Hartmann A, Housawi A, House A, Ng C, Denesyk K, Rehman F, Moist L, Musetti C, Battista M, Izzo C, Guglielmetti G, Airoldi A, Stratta P, Musetti C, Cena T, Quaglia M, Fenoglio R, Cagna D, Airoldi A, Amoroso A, Stratta P, Palmisano A, Degli Antoni AM, Vaglio A, Piotti G, Cremaschi E, Buzio C, Maggiore U, Lee MC, Hsu BG, Zalamea Jarrin F, Sanchez Sobrino B, Lafuente Covarrubias O, Karsten Alvarez S, Dominguez Apinaniz P, Llopez Carratala R, Portoles Perez J, Yildirim T, Yilmaz R, Turkmen E, Altindal M, Arici M, Altun B, Erdem Y, Dounousi E, Mitsis M, Naka K, Pappas H, Lakkas L, Harisis H, Pappas K, Koutlas V, Tzalavra I, Spanos G, Michalis L, Siamopoulos K, Iwabuchi T, Yagisawa T, Kimura T, Nanmoku K, Kurosawa A, Yasunaru S, Lee MC, Hsu BG, Yoshikawa M, Kitamura K, Fuji H, Fujisawa M, Nishi S, Carta P, Zanazzi M, Buti E, Larti A, Caroti L, Di Maria L, Minetti EE, Shi Y, Luo L, Cai B, Wang T, Zou Y, Wang L, Kim Y, Kim HS, Choi BS, Park CW, Yang CW, Kim YS, Chung BH, Baek CH, Kim M, Kim JS, Yang WS, Han DJ, Park SK, Mikolasevic I, Racki S, Lukenda V, Persic MP, Colic M, Devcic B, Orlic L, Sezer S, Gurlek Demirci B, Guliyev O, Colak T, Say N CB, Ozdemir Acar FN, Haberal M, Vali S, Ismal K, Sahay M, Civiletti F, Cantaluppi V, Medica D, Mazzeo AT, Assenzio B, Mastromauro I, Deambrosis I, Giaretta F, Fanelli V, Mascia L, Musetti C, Airoldi A, Quaglia M, Guglielmetti G, Battista M, Izzo C, Stratta P, Lakkas L, Naka K, Dounousi E, Koutlas V, Gkirdis I, Bechlioulis A, Evangelou D, Zarzoulas F, Kotsia A, Balafa O, Tzeltzes G, Nakas G, Pappas K, Kalaitzidis R, Katsouras C, Michalis L, Siamopoulos K, Tutal E, Erkmen Uyar M, Uyanik S, Bal Z, Guliyev O, Toprak SK, Ilhan O, Sezer S, Bal Z, Ekmen Uyar M, Guliyev O, Sayin B, Colak T, Sezer S, Haberal M, Hernandez Vargas H, Artamendi Larranaga M, Ramalle Gomara E, Gil Catalinas F, Bello Ovalle A, Pimentel Guzman G, Coloma Lopez A, Sierra Carpio M, Gil Paraiso A, Dall Anesse C, Beired Val I, Huarte Loza E, Choy BY, Kwan L, Mok M, Chan TM, Yamakawa T, Kobayashi A, Yamamoto I, Mafune A, Nakada Y, Tannno Y, Tsuboi N, Yamamoto H, Yokoyama K, Ohkido I, Yokoo T, Luque Y, Anglicheau D, Rabant M, Clement R, Kreis H, Sartorius A, Noel LH, Timsit MO, Legendre C, Rancic N, Vavic N, Dragojevic-Simic V, Katic J, Jacimovic N, Kovacevic A, Mikov M, Veldhuijzen NMH, Rookmaaker MB, Van Zuilen AD, Nquyen TQ, Boer WH, Mjoen G, Pihlstrom H, Dahle DO, Holdaas H, Sahtout W, Ghezaiel H, Azzebi A, Ben Abdelkrim S, Guedri Y, Mrabet S, Nouira S, Ferdaws S, Amor S, Belarbia A, Zellama D, Mokni M, Achour A, Viklicky O, Parikova A, Slatinska J, Hanzal V, Fronek J, Orandi BJ, James NT, Montgomery RA, Desai NM, Segev DL, Fontana F, Ballestri M, Magistroni R, Damiano F, Cappelli G. TRANSPLANTATION CLINICAL 1. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
28
|
Neves FMDO, Leite TT, Meneses GC, Araujo De Souza NH, Martins AMC, Parahyba MC, Queiroz REB, Liborio A, Liu Y, Li Y, Li X, Chen L, Zulkarnaev A, Vatazin A, Nikolaj S, Stadler T, Raddatz A, Hubner W, Poppleton A, Fliser D, Klingele M, Castellano G, Intini A, Stasi A, Divella C, Pontrelli P, Gigante M, Zito A, Pertosa GB, Gesualdo L, Grandaliano G, Powell TC, Donnelly JP, Wang HE, Warnock DG, De Loor J, Hoste E, Herck I, Francois K, Decrop L, Clauwaert C, Bracke S, Vermeiren D, Demeyere K, Meyer E, Mitra P, Rahim MA, Gupta RD, Samdani TS, Rahman SA, Enam SF, Mursalin G, E-Khoda MM, Haque WMM, Iqbal S, Mansur MA, Guglielmetti G, Cena T, Musetti C, Quaglia M, Battista M, Radin E, Airoldi A, Izzo C, Stratta P, Haase-Fielitz A, Albert C, Westphal S, Hoffmann J, Mertens PR, Plass M, Westerman M, Bellomo R, Maisel A, Ronco C, Haase M, Wu PC, Wu VC, Prasad B, Wong B, St.Onge JR, Rungta R, Das P, Ray DS, Gupta S, De Gracia MDC, Osuna A, Quesada A, Manzano F, Montoro S, Jimenez MDM, Wangensteen R, Strunk AK, Schmidt J, Schmidt B, Bode-Boger S, Martens-Lobenhoffer J, Welte T, Kielstein JT, Wang AY, Bellomo R, Cass A, Myburgh J, Finfer S, Gatta D, Chadban S, Jardine M, Lo S, Barzi F, Gallagher M, Marn-Pernat A, Benedik M, Bren A, Buturovic-Ponikvar J, Gubensek J, Knap B, Premru V, Ponikvar R, Koba L, Teixeira M, Macedo E, Altunoren O, Balli M, Tasolar H, Eren N, Arpaci A, Caglayan CE, Yavuz YC, Sahin M, Gliga ML, Gliga PM, Frigy A, Bandea A, Magdas AM, Dogaru G, Mergulhao C, Pinheiro H, Vidal E, Sette L, Amorim G, Fernandes G, Valente L, Hornum M, Penninga L, Rasmussen A, Plagborg UB, Oturai P, Feldt-Rasmussen B, Hillingso JG, Klimenko A, Villevalde S, Kobalava Z, Arias Cabrales C, Rodriguez E, Bermejo S, Sierra A, Pascual J, Huang TM, Wu VC, Oh WC, Rigby M, Mafrici B, Sharman A, Harvey D, Welham S, Mahajan R, Gardner D, Devonald M, Wu VC, Lin MC, Wu PC, Wu CH, Nagaraja P, Clark A, Brisk R, Jennings V, Jones H, Hashmi M, Parker C, Mikhail A, Schraut J, Keller F, Mertens T, Duprel JB, Quercia AD, Cantaluppi V, Dellepiane S, Pacitti A, Biancone L, Chang KY, Park HS, Kim HW, Choi BS, Park CW, Yang CW, Jin DC, Quercia AD, Cantaluppi V, Dellepiane S, Medica D, Besso L, Gai M, Leonardi G, Guarena C, Biancone L, Obrencevic K, Jovanovic D, Petrovic M, Ignjatovic L, Tadic J, Mijuskovic M, Maksic D, Vavic N, Pilcevic D, Mistry HD, Bramham K, Seed PT, Lynham S, Ward MA, Poston L, Chappell LC. CLINICAL ACUTE KIDNEY INJURY 1. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Van Londen M, Humalda JK, Aarts BM, Sanders JS, Bakker SJL, Navis GJ, De Borst MH, Pazik J, O Dak M, Lewandowski Z, Podgorska M, Sadowska A, Sitarek E, Malejczyk J, Durlik M, Drechsler C, Philstrom H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine A, Wanner C, Maerz W, Holdaas H, Halleck F, Staeck O, Neumayer HH, Budde K, Khadzhynov D, Rostaing L, Allal A, Congy N, Aarninck A, Del Bello A, Maggioni S, Debiols B, Sallusto F, Kamar N, Stolyarevich E, Artyukhina L, Kim I, Tomilina N, Zaidenov V, Kurenkova L, Keyzer CA, De Borst MH, Van Den Berg E, Jahnen-Dechent W, Navis G, Bakker SJL, Van Goor H, Pasch A, Aulagnon F, Avettand-Fenoel V, Scemla A, Lanternier F, Lortholary O, Anglicheau D, Legendre C, Zuber J, Furic-Cunko V, Basic-Jukic N, Coric M, Kastelan Z, Hudolin T, Kes P, Mikolasevic I, Racki S, Lukenda V, Orlic L, Dobrowolski LC, Verberne HJ, Ten Berge IJM, Bemelman FJ, Krediet CTP, Ferreira AC, Silva C, Remedio F, Pena A, Nolasco F, Heldal K, Lonning K, Leivestad T, Reisaeter AV, Hartmann A, Foss AE, Midtvedt K, Vlachopanos G, Kassimatis T, Zerva A, Kokkona A, Stavroulaki E, Agrafiotis A, Sanchez Sobrino B, Lafuente Covarrubias O, Karsten Alvarez S, Zalamea Jarrin F, Rubio Gonzalez E, Huerta Arroyo A, Portoles Perez J, Basic-Jukic N, Kes P, Baek CH, Kim M, Kim JS, Yang WS, Han DJ, Park SK, Zulkarnaev A, Vatazin A, Cabiddu G, Maxia S, Castellino S, Loi V, Guzzo G, Piccoli GB, Pani A, Bucsa C, Tacu D, Harza M, Sinescu I, Mircescu G, Stefan G, Alfieri CM, Laura F, Danilovic B, Cresseri D, Meneghini M, Riccardo F, Regalia A, Messa P, Panuccio V, Tripepi R, Parlongo G, Quattrone S, Leonardis D, Tripepi G, Zoccali C, Mallamaci F, Amer H, Geerdes PA, Fettes TT, Prieto M, Walker RC, Edwards BS, Cosio FG, Khrabrova M, Nabokov A, Groene HJ, Weithofer P, Kliem V, Smirnov A, Dobronravov V, Sezer S, Gurlek Demirci B, Tutal E, Guliyev O, Say N CB, Ozdemir Acar FN, Haberal M, Albugami MM, Hussein M, Alsaeed S, Almubarak A, Bel'eed-Akkari K, Go biewska JE, Tarasewicz A, D bska- lizie A, Rutkowski B, Albugami MM, Hussein M, Almubarak A, Alsaeed S, Bel'eed-Akkari K, Ailioaie O, Arzouk N, Tourret J, Mercadal L, Szumilak D, Ourahma S, Parra J, Billault C, Barrou B, Alfieri CM, Floreani R, Ulivieri FM, Meneghini M, Regalia A, Zanoni F, Croci D, Rastaldi MP, Messa PG, Keyzer CA, Riphagen IJ, Joosten MM, Navis G, Muller Kobold AC, Kema IP, Bakker SJL, De Borst MH, Santos Lascasas J, Malheiro J, Fonseca I, Martins L, Almeida M, Pedroso S, Dias L, Henriques A, Cabrita A, Vincenti F, Weir M, Von Visger J, Kopyt N, Mannon R, Deng H, Yue S, Wolf M, Halleck F, Khadzhynov, D, Schmidt D, Petereit F, Slowinski T, Neumayer HH, Budde K, Staeck O, Hernandez Vargas H, Artamendi Larranaga M, Gil Catalinas F, Ramalle Gomara E, Bello Ovalle A, Pimentel Guzman G, Coloma Lopez A, Dall Anesse C, Gil Paraiso A, Beired Val I, Sierra Carpio M, Huarte Loza E, Slubowska K, Szmidt J, Chmura A, Durlik M, Staeck O, Khadzhynov D, Schmidt D, Niemann M, Petereit F, Lachmann N, Neumayer HH, Budde K, Halleck F, Alotaibi T, Nampoory N, Gheith O, Halim M, Aboatteya H, Mansour H, Abdulkawey H, Said T, Nair P, WazNa-Jab O Ska E, Durlik M, Elias M, Caillard S, Morelon E, Rivalan J, Moal V, Frimat L, Mourad G, Rerolle JP, Legendre C, Mousson C, Delahousse M, Pouteil-Noble C, Dantal J, Cassuto E, Subra JF, Lang P, Thervet E, Roosweil D, Molnar MZ, Fornadi K, Ronai KZ, Novak M, Mucsi I, Scale TM, Robertson S, Kumwenda M, Jibani M, Griffin S, Williams AJ, Mikhail A, Jeong JC, Koo TY, Jeon HJ, Han M, Oh KH, Ahn C, Yang J, Bancu I, Canas L, Juega J, Malumbres S, Guermah I, Bonet J, Lauzurica R, Basso E, Messina M, Daidola G, Mella A, Lavacca A, Manzione AM, Rossetti M, Ranghino A, Ariaudo C, Segoloni GP, Biancone L, Whang E, Son SH, Kwon H, Kong JJ, Choi WY, Yoon CS, Ferreira AC, Silva C, Aires I, Ferreira A, Remedio F, Nolasco F, Ratkovic M, Basic Jukic N, Gledovic B, Radunovic D, Prelevic V, Stefan G, Garneata L, Bucsa C, Harza M, Sinescu I, Mircescu G, Tacu D, Aniort J, Kaysi S, Mulliez A, Heng AE, Su owicz J, Wojas-Pelc A, Ignacak E, Janda K, Krzanowski M, Miarka P, Su owicz W, Filipov JJ, Zlatkov BK, Dimitrov EP, Svinarov DA, Champion L, Renoux C, Randoux C, Du Halgouet C, Azeroual L, Glotz D, Vrtovsnik F, Daugas E, Musetti C, Battista M, Cena T, Izzo C, Airoldi A, Magnani C, Stratta P, Fiskvik I, Holte H, Bentdal O, Holdaas H, Erkmen Uyar M, Sezer S, Bal Z, Guliyev O, Colak T, Gurlek Demirci B, Ozdemir Acar N, Haberal M, Kara E, Ahbap E, Basturk T, Koc Y, Sakaci T, Sahutoglu T, Akgol C, Sevinc M, Unsal A, Seyahi N, Abdultawab K, Alotaibi T, Gheith O, Mansour H, Halim M, Nair P, Said T, Balaha M, Elsayed A, Awadeen W, Nampoory N, Hwang JC, Jiang MY, Lu YH, Weng SF, Madziarska K, Zmonarski SC, Augustyniak-Bartosik H, Magott-Procelewska M, Krajewska M, Mazanowska O, Banasik M, Penar J, Weyde W, Boraty Ska M, Klinger M, Swarnalatha G, Narendranath L, Shanta Rao G, Sawhney A, Subrahmanyam L, Kumar S, Jeon H, Hakim A, Patel U, Shrivastava S, Banerjee D, Kimura T, Yagisawa T, Nanmoku K, Kurosawa A, Sakuma Y, Miki A, Nukui A, Lee CH, Oh IH, Park JS, Watarai Y, Narumi S, Goto N, Hiramitsu T, Tsujita M, Yamamoto T, Kobayashi T, Muniz Pacios L, Molina M, Cabrera J, Gonzalez E, Garcia Santiago A, Aunon P, Santana S, Polanco N, Gutierrez E, Jimenez C, Andres A, Mohammed M, Hammam M, Housawi A, Goldsmith DJ, Cronin A, Frame S, Smalcelj R, Canoz MB, Yavuz DD, Altunoglu A, Yavuz R, Colak T, Haberal M, Tong A, Hanson CS, Chapman JR, Halleck F, Budde K, Papachristou C, Craig J, Zheng XY, Han S, Wang LM, Zhu YH, Zeng L, Zhou MS, Guliyev O, Erkmen Uyar M, Sezer S, Bal Z, Colak T, Gurlek Demirci B, Ozdemir Acar N, Haberal M, Ranghino A, Diena D, De Rosa FG, Faletti R, Barbui AM, Guarnaccia C, Corcione S, Messina M, Ariaudo C, Segoloni GP, Biancone L, Patel R, Murray PD, Moiseev A, Kalachik A, Harden PN, Norby G, Mjoen G, Holdaas H, Gilboe IM, Shi Y, Luo L, Cai B, Wang T, Tao Y, Wang L, Erkmen Uyar M, Sezer S, Bal Z, Guliyev O, Tutal E, Gurlek Demirci B, Ozdemir Acar N, Haberal M, Di Vico MC, Messina M, Mezza E, Giraudi R, Nappo A, Boaglio E, Ranghino A, Fop F, Segoloni GP, Biancone L, Carta P, Dattolo E, Buti E, Zanazzi M, Villari D, Di Maria L, Santoro G, Li Marzi V, Minetti EE, Nicita G, Carta P, Zanazzi M, Buti E, Antognoli G, Dervishi E, Vignali L, Caroti L, Di Maria L, Minetti EE, Dorje C, Kovacevic G, Hammarstrom C, Strom EH, Holdaas H, Midtvedt K, Reisaeter AV, Alfieri CM, Floreani R, Meneghini M, Regalia A, Zanoni F, Vettoretti S, Croci MD, Rastaldi MP, Messa P, Heldal K, Lonning K, Reisaeter AV, Bernklev T, Midtvedt K, Strakosha A, Pasko N, Nasto F, Cadri V, Dedei A, Thereska N. TRANSPLANTATION CLINICAL 2. Nephrol Dial Transplant 2014. [DOI: 10.1093/ndt/gfu180] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
30
|
de Corso E, Battista M, Pandolfini M, Liberati L, Baroni S, Romanelo M, Passali G, Fetoni A, Sergi B, Di Nardo W, Paludetti G. Role of inflammation in non-allergic rhinitis. Rhinology 2014. [DOI: 10.4193/rhin13.102] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
31
|
Dor-Nedonsel E, Maria F, Tosello AL, Battista M, Thümmler S, Boublil M, Messana M, Poinso F, Salle-Colmiche X, Iakimova G, Fontas E, Askenazy F. 1948 – Chilhood onset schizophrenia: Epidemiological and clinical preliminary findings from a french population-based study. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)76890-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
32
|
Dor-Nedonsel E, Battista M, Serpa-Rouede A, Chanson PY, Askenazy F. 1988 – Looking after anorexia nervosa: an inovative way of caring. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)76925-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
33
|
Battista M, Celse C. 1624 – Prospective evaluation of sensorial trainings on body mass index in anorexia nervosa. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)76618-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
34
|
Schmidt M, van de Sandt L, Boehm D, Sicking I, Battista M, Lebrecht A, Solbach C, Koelbl H, Gehrmann M, Rahnenführer J, Hengstler JG. Abstract P2-10-13: CD4 positive tumor-infiltrating lymphocytes are associated with improved prognosis in node-negative breast cancer. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p2-10-13] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The prognostic significance of CD8 positive cytotoxic lymphocytes in breast cancer is well accepted. However, the role of CD4 positive lymphocytes is ambiguous. We examined the prognostic relevance of CD4 positive tumor-infiltrating lymphocytes in previously published node-negative breast cancer cohorts using RNA expression.
Methods: Microarray based gene-expression data for CD4 (203547_at) were analyzed in four previously published cohorts (Mainz, Rotterdam, Transbig, Yu) of node-negative breast cancer patients not treated with adjuvant therapy (n = 824). A meta-analysis of previously published cohorts was performed using a random effects model. Prognostic significance of CD4 on metastasis-free survival (MFS) was examined in the whole cohort and in different molecular subtypes (ER+/HER2−, ER−/HER2−, HER2+). Independent prognostic relevance was analyzed using multivariate Cox regression.
Results: Higher RNA expression of CD4 was related to better MFS in a meta-analysis of the whole cohort (HR 0.66, 95% CI 0.49–0.90, p = 0.0074). Prognostic significance was most pronounced in the HER2+ positive molecular subtype (HR 0.32, 95% CI 0.14–0.75, p = 0.0091) as compared to ER+/HER2− (HR 0.62, 95% CI 0.29–1.32, P>0.05) and ER−/HER2− (HR 0.61, 95% CI 0.28–1.35, P>0.05) carcinomas of the breast. CD4 showed independent prognostic significance (HR 0.60, 95% CI 0.37–0.96, p = 0.032) in multivariate analysis. In addition to CD4, only histological grade of differentiation (HR 2.43, 95% CI 1.50–3.94, P < 0.001) and tumor size (HR 1.87, 95% CI 1.19–2.94, p = 0.007), but not age, HER2 status or hormone receptor status retained an independent prognostic association with MFS.
Conclusion: CD4 positive tumor-infiltrating lymphocytes have independent prognostic significance in node-negative breast cancer. A higher expression is associated with improved outcome.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P2-10-13.
Collapse
Affiliation(s)
- M Schmidt
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - L van de Sandt
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - D Boehm
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - I Sicking
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - M Battista
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - A Lebrecht
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - C Solbach
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - H Koelbl
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - M Gehrmann
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - J Rahnenführer
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| | - JG Hengstler
- University Hospital, Mainz, Germany; Technical University, Dortmund, Germany; Bayer, Leverkusen, Germany; Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany
| |
Collapse
|
35
|
Guida M, Gallé F, Di Onofrio V, Nastro RA, Battista M, Liguori R, Battista F, Liguori G. Environmental microbial contamination in dental setting: a local experience. J Prev Med Hyg 2012; 53:207-212. [PMID: 23469590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
INTRODUCTION Patients and operators are exposed during dental practice to an infective risk, which derives especially from microorganisms suspended in aerosols. Environmental microbiological monitoring in dental settings represents a good instrument to detect critical situations. METHODS In order to investigate environmental microbial contamination level in a local reality, we analyzed water, air and surfaces samples of a community-based dental facility by using protocol and threshold values proposed in a recent multicenter study carried out by the Italian Society of Hygiene, Preventive Medicine and Public Health (S.It.I.) working group "Hygiene in Dentistry". Microbial contamination was assessed in the same room for 4 non-consecutive weeks during all the five working days, before and at the end of the daily activity. Air was sampled also during clinical activity, through both active and passive sampling systems. RESULTS Contamination of water showed a decrease during activities, while a decrease in air contamination was registered only at the end of the day. Passive sampling values resulted more often above threshold values adopted. At the same time, surfaces contamination increases at the end of the activity. It seems that in the dental clinic analyzed microbial buildup represents the higher critical element. No differences have been registered among the different days of the week. DISCUSSION Our study highlights the need to improve disinfection procedures and air treatment systems in the considered environment. Microbiological monitoring could represent an important element to detect the presence of risk factors and to adopt control measures.
Collapse
Affiliation(s)
- M Guida
- Department of Structural and Functional Biology, University of Naples Federico II, Italy
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Böhm D, Kubitza A, Lebrecht A, Schmidt M, Gerhold-Ay A, Battista M, Stewen K, Solbach C, Kölbl H. Prospective randomized comparison of conventional instruments and the Harmonic Focus® device in breast-conserving therapy for primary breast cancer. Eur J Surg Oncol 2012; 38:118-24. [DOI: 10.1016/j.ejso.2011.11.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2011] [Revised: 10/30/2011] [Accepted: 11/15/2011] [Indexed: 10/14/2022] Open
|
37
|
Ongaro A, Pellati A, Caruso A, Battista M, De Terlizzi F, De Mattei M, Fini M. Identification of In Vitro Electropermeabilization Equivalent Pulse Protocols. Technol Cancer Res Treat 2011; 10:465-73. [DOI: 10.7785/tcrt.2012.500223] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Exposure of cells to an external sufficiently strong electric field results in the formation of pores across the membrane. This phenomenon, termed electropermeabilization, permits the transport of poorly permeant molecules into cytosol. In clinical practice, cell membrane permeabilization for drug electrotransfer is achieved using the ESOPE pulse protocol (1000 V/cm, 8 pulses, 100 μs, 5 kHz). The aim of this study was to investigate several combinations of electric field amplitude and pulse number able to induce electropermeabilization as the one observed when the ESOPE protocol was applied. Decreasing electric field amplitudes (1000 to 300 V/cm) in combination with increasing number of pulses (8 to 320) were applied to in vitro MG63 cells. Propidium iodide and Calcein blue AM uptake were used to evaluate cell electropermeabilization and viability. Results showed that the threshold of local electric field needed to obtain electropermeabilization decreased exponentially with increasing the number of pulses delivered (r2 50.92, p < 0.0001). The absorbed dose threshold was dependent on the number of pulses for each voltage applied (r2 50.96, p < 0.0001). In conclusion, the possibility of applying an increased number of pulses rather than increasing the electric field amplitude to perform electropermeabilization, may become an important tool for electropermeabilization - related clinical applications.
Collapse
Affiliation(s)
- A. Ongaro
- Department of Morphology and Embryology, University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy
| | - A. Pellati
- Department of Morphology and Embryology, University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy
| | - A. Caruso
- Department of Morphology and Embryology, University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy
| | - M. Battista
- Laboratory of Clinical Biophysics, IGEA, Carpi, Italy
| | | | - M. De Mattei
- Department of Morphology and Embryology, University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy
| | - M. Fini
- Laboratory of Preclinical and Surgical Studies, Research Institute Codivilla Putti, Rizzoli Orthopaedic Institute Bologna, Italy
| |
Collapse
|
38
|
Dar A, Schajnovitz A, Lapid K, Kalinkovich A, Itkin T, Ludin A, Kao WM, Battista M, Tesio M, Kollet O, Cohen NN, Margalit R, Buss EC, Baleux F, Oishi S, Fujii N, Larochelle A, Dunbar CE, Broxmeyer HE, Frenette PS, Lapidot T. Erratum: Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells. Leukemia 2011. [DOI: 10.1038/leu.2011.132] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
39
|
Battista MJ, Steetskamp J, Mantai N, Gebhard S, Cotarelo C, Victor A, Petry I, Schmidt M, Kölbl H. Immunoreactive score of Ep-CAM might predict survival in early ovarian cancer patients. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1286464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
40
|
Schmidt M, Battista M, Nilges K, Teifke A, Kölbl H. Nachsorge nach Mammakarzinom und gynäkologischen Karzinomen. Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1186169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
41
|
Battista MJ, Steiner E, Zabel N, Schmidt M, Kölbl H. Ausgangslage für die S2-Leitlinie der Arbeitsgemeinschaft Gynäkologische Onkologie Kommission Uterus zur Therapie des Endometriumkarzinom in Deutschland. Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1238925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
42
|
D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines. J BIOL REG HOMEOS AG 2009; 23:155-164. [PMID: 19828092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The level of CD81 cell surface expression, a cellular co-receptor for hepatitis C virus (HCV), is critical for productive HCV infection of host cells. In addition, the cross-linking of HCV-E2 protein to CD81 can alter the function of T and B lymphocytes as well as that of NK cells by interfering with the activation signalling pathway. The down-regulation of CD81 expression on peripheral blood lymphocytes (PBL) has been associated to effective therapy of HCV infection. The aim of the present study is to quantitatively assess the levels of CD81 expression in PBL from HCV-infected patients compared to subjects at high risk for HCV infection such as HIV-infected individuals or patients with Porphyria Cutanea Tarda (PCT). The expression of CD81 was quantified by flow-cytometry using Phycoerythrin-labelled standard beads. Determination of CD81 was performed on CD3+ and CD19+ lymphocytes from 34 healthy controls, 51 patients with HCV infection and different clinical outcomes [these included HCV-RNA-negative subjects (8), patients with chronic active hepatitis (16), recipients of liver transplantation under immunosuppressive therapy (12), a subgroup with concomitant HIV infection (9) or concomitant PCT (6)]. In addition, 60 HIV-infected subjects and 4 patients with PCT were studied. The putative role of inflammatory cytokines in modulating CD81 was explored in vitro by assessing the effect of IL-6 or IFN-gamma on cultured human hepatocytes. A significant increase of the CD81 expression was found on CD19+ lymphocytes in association with either HIV or HCV infection, as compared to the control group. Immunosuppressive therapy with FK506, subsequent to liver transplantation, restored CD81 expression at normal levels. Data gathered in vitro using the WRL 68 hepatocytic cell line confirmed that inflammatory cytokines can up-regulate CD81 expression in liver cell inclusion. Our data suggest that CD81 up-regulation can increase the risk of HCV infection, particularly in HIV-infected subjects. In addition, the results strongly suggest that the cytokines released by activated lymphocytes at sites of inflammation may play a part in up-regulating CD81 expression.
Collapse
Affiliation(s)
- G D'Agosto
- Department of Clinical Pathology and Microbiology, San Gallicano Dermatology Institute, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Zaja F, Tomadini V, Zaccaria A, Lenoci M, Battista M, Molinari AL, Fabbri A, Battista R, Cabras MG, Gallamini A, Fanin R. CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma. Leuk Lymphoma 2009; 47:2174-80. [PMID: 17071492 DOI: 10.1080/10428190600799946] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Thirty untreated patients, median age 69 years (range 60 - 75 years), with diffuse large B-cell lymphoma (B-DLCL) were treated with a pegylated liposomal doxorubicin (PL-doxorubicin) modified CHOP-rituximab regimen. PL-doxorubicin 30 mg/m2, was given in combination with standard dosage of prednisone, vincristine, cyclophosphamide, rituximab (according to CHOP-R regimen) every 21 days for six courses. Cardiac toxicity was evaluated by mean of echocardiography for left ventricular ejection fraction (LVEF) evaluations and serum troponin-I levels. Overall response and complete response rates were 76% and 59%. Projected two year event free survival and overall survival are 65.5% and 68.5%. No treatment-related mortality was documented. WHO grade III-IV neutropenia and thrombocytopenia were 86% and 3%. Extra-hematological III-IV toxicity was represented, respectively, by a single case of infection, mucositis, and bleeding. LVEF evaluations and the troponin levels did not show significant changes over the course of the treatment. One patient with a previous history of atrial fibrillation experienced a single episode of arrhythmia. None of the patients developed palmar-plantar erythrodysesthesia. This regimen appears an active regimen for the treatment of elderly patients with B-DLCL. The replacement of conventional doxorubicin with PL-doxorubicin seems to be associated with a negligible incidence of extra-hematological toxicity, in particular cardiac and infectious complications.
Collapse
Affiliation(s)
- F Zaja
- Division of Hematology, DIRM, University Hospital, Udine, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Toffoletti E, Zaja F, Chiarvesio A, Michelutti A, Battista M, Fanin R. No evidences for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy. Haematologica 2008; 93:795-6. [DOI: 10.3324/haematol.12241] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
45
|
Battista MJ, Maul H, Krause M, Freerksen N, Beuter P, Freerksen N, Sohn C. Gabe von Fenoterol bei Patientin mit Cervix-insuffizienz demaskiert Dystrophe Myotonie Typ I (M. Curschmann-Steinert)- case report. Z Geburtshilfe Neonatol 2007. [DOI: 10.1055/s-2007-1002981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
46
|
Hertler S, Maul H, Battista M, Freerksen N, Sicking I, Sohn C. Cerclage aus Sicht der Schwangeren–Retrospektive Analyse. Z Geburtshilfe Neonatol 2007. [DOI: 10.1055/s-2007-1002924] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
47
|
Rizzo C, Dell’Aquila L, Ceci G, Battista M, De Pascale G, Coscia M, Monno R, De Vito D, Rizzo G. UTILIZZO DI TABELLE STANDARD NELLA GESTIONE DEL LABORATORIO DI MICROBIOLOGIA. Microbiol Med 2006. [DOI: 10.4081/mm.2006.3282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
48
|
Yesavage JA, Sheikh J, Noda A, Murphy G, O'Hara R, Hierholzer R, Battista M, Ashford JW, Schneider B, Hoblyn J, Kraemer HC, Tinklenberg J. Spatial test for agricultural pesticide "blow-in" effect on prevalence of Parkinson's disease. J Geriatr Psychiatry Neurol 2006; 19:32-5. [PMID: 16449758 DOI: 10.1177/0891988705284707] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
The current study used Department of Veteran's Affairs (VA) clinical records, State of California pesticide application records, spatial maps of distribution of Parkinson's disease patients, and pesticide applications to determine if there was evidence for "blow-in" of pesticides as a factor in explaining the prevalence of Central Valley Parkinson's disease. The results did not support the hypothesis of increasing prevalence of Parkinsonism attributable to wind drift.
Collapse
Affiliation(s)
- J A Yesavage
- Sierra-Pacific Mental Illness Research, Education, and Clinical Center, Palo Alto Veterans Affairs Health Care System, Palo Alto, CA 94304, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Balbi GC, Cardone A, Monteverde A, Passaro M, Montone L, Rossiello R, Visconti S, Battista M, Battisti M, Cassese E, Landino I. Double laparotomy wound recurrence of endometrial carcinoma. EUR J GYNAECOL ONCOL 2006; 27:307-9. [PMID: 16800268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
INTRODUCTION Abdominal scar recurrence of endometrial carcinoma after abdominal total hysterectomy is very rare. We report a case of a 65-year-old woman who had two recurrences in the abdominal incisional scar after total hysterectomy. CASE REPORT A 65-year-old woman underwent total hysterectomy with bilateral salpingo-oophorectomy and pelvic lymphadenectomy because of well-differentiated endometrial adenocarcinoma (Stage IIB). Thus, the patient was treated by external beam radiotherapy. She developed two recurrences in the abdominal incisional scar two and three years after total hysterectomy, respectively. Surgery plus chemotherapy and surgery plus hormonal therapy were used for treatment of the first and second scar recurrence, respectively. CONCLUSIONS It is a very intriguing and controversial biologic question how neoplastic cells can implant and grow in an abdominal scar without other concomitant metastases. We report a review of the literature and the possible mechanism of recurrences in laparotomy wounds.
Collapse
Affiliation(s)
- G C Balbi
- Department of Obstetrics and Gynecology, Department of Pathological Anatomy, L. Armanni Second University of Naples (SUN), Naples, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Zaja F, Tomadini V, Zaccaria A, Lauria F, Molinari AL, Fabbri A, Battista R, Angelucci E, Gallamini A, Battista M, Fanin R. Liposomal doxorubicin-liposomal doxorubicin-rituximab for the treatment of elderly patients with diffuse large B-cell lymphoma. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.6687] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- F. Zaja
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - V. Tomadini
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - A. Zaccaria
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - F. Lauria
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - A. L. Molinari
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - A. Fabbri
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - R. Battista
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - E. Angelucci
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - A. Gallamini
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - M. Battista
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| | - R. Fanin
- Div of Hematology, Policlinico Univ, Udine, Italy; Div of Hematology, Ravenna, Italy; Div of Hematology, Siena, Italy; Div of Hematology, Chioggia, Italy; Div of Hematology, Cagliari, Italy; Div of Hematology, Cuneo, Italy
| |
Collapse
|